RAPT Therapeutics Inc. (RAPT)
NASDAQ: RAPT
· Real-Time Price · USD
11.79
0.54 (4.80%)
At close: Aug 15, 2025, 3:59 PM
11.65
-1.18%
After-hours: Aug 15, 2025, 06:13 PM EDT
RAPT Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 41.89M | 60.26M | 169.74M | 37.9M | 37.08M | 45.32M | 47.48M | 54.13M | 50.16M | 45.77M | 38.95M | 27.71M | 57.2M | 32.42M | 24.03M | 60M | 86.22M | 24.72M |
Short-Term Investments | 127.06M | 119.02M | 61.32M | 60.01M | 77.76M | 96.26M | 111.38M | 130.64M | 154.83M | 185.86M | 210.12M | 167.73M | 150.14M | 140.59M | 165.63M | 150.79M | 137.08M | 73.69M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 2.27M | 389K | 389K | 389K | 447K | 447K | 3.87M | 4.21M | 4.27M | 4.21M | 4.04M | 3.07M | 3.09M | 2.93M | 2.92M | 389K | 389K | 389K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 3.91M | 3.92M | 4.18M | 4.69M | 5.66M | 6.78M | 2.92M | 2.36M | 2.42M | 2.96M | 3.63M | 2.46M | 2.59M | 2.66M | 3.32M | 3.71M | 4.65M | 4.2M |
Total Current Assets | 172.86M | 183.2M | 235.24M | 102.6M | 120.5M | 148.36M | 161.78M | 187.14M | 207.42M | 234.59M | 252.69M | 197.89M | 209.93M | 175.66M | 192.97M | 214.5M | 227.96M | 102.61M |
Property-Plant & Equipment | 3.28M | 3.98M | 4.7M | 5.48M | 6.24M | 7.01M | 7.68M | 8.38M | 9.07M | 9.53M | 9.48M | 8.52M | 8.98M | 8.95M | 2.74M | 2.58M | 2.74M | 2.93M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 5.55M | 4.37M | 5.09M | 5.87M | 6.68M | 7.46M | 11.55M | 12.58M | 13.34M | 13.74M | 13.52M | 11.6M | 12.07M | 11.88M | 5.66M | 2.97M | 3.13M | 3.32M |
Total Assets | 178.41M | 187.57M | 240.32M | 108.47M | 127.18M | 155.82M | 173.33M | 199.72M | 220.76M | 248.33M | 266.21M | 209.49M | 222M | 187.55M | 198.64M | 217.46M | 231.08M | 105.92M |
Account Payables | 4.19M | 1.29M | 1.27M | 1.38M | 2.72M | 6.77M | 5.18M | 5.3M | 2.69M | 8.94M | 3.37M | 4.04M | 4.1M | 1.94M | 2M | 4.02M | 2.71M | 3.13M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 14.11M | 10.29M | n/a | n/a | n/a | n/a | 645K | 1.02M | 1.54M | 2.28M | 3.13M |
Short-Term Debt | 2.21M | n/a | n/a | n/a | 2.57M | n/a | 2.45M | 2.39M | 2.33M | 2.28M | n/a | 1.55M | 1.5M | 1.48M | n/a | n/a | n/a | n/a |
Other Current Liabilities | 3.3M | 2.83M | 6.78M | 4.93M | 2.33M | 82K | 5.46M | 3.17M | 1.73M | 4.98M | 32K | 2.78M | 3.17M | 4.46M | 2.93M | 3.96M | 3.13M | 2.71M |
Total Current Liabilities | 13.04M | 8.68M | 48.35M | 10.36M | 14.8M | 21.17M | 21.84M | 21.85M | 15.41M | 21.61M | 14.22M | 13.87M | 13.15M | 12.36M | 9.6M | 12.7M | 10.39M | 11.14M |
Long-Term Debt | 959K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.15M | 2.15M | 2.14M | 2.16M |
Total Long-Term Liabilities | 959K | 1.52M | 2.07M | 2.6M | 3.16M | 3.81M | 4.46M | 5.07M | 5.67M | 6.25M | 6.82M | 6.32M | 6.72M | 7.35M | 2.66M | 2.89M | 3.11M | 3.14M |
Total Liabilities | 14M | 10.2M | 50.42M | 12.96M | 17.96M | 24.98M | 26.29M | 26.92M | 21.08M | 27.86M | 21.04M | 20.18M | 19.86M | 19.71M | 12.26M | 15.59M | 13.5M | 14.28M |
Total Debt | 3.16M | 3.83M | 4.49M | 5.12M | 5.73M | 6.32M | 6.91M | 7.46M | 8M | 8.53M | 8.99M | 7.87M | 8.22M | 8.59M | n/a | n/a | n/a | n/a |
Common Stock | 13K | 13K | 13K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 2K |
Retained Earnings | -649.36M | -631.71M | -614.55M | -561.3M | -542.87M | -515.2M | -484.68M | -453.81M | -422.44M | -397.15M | -367.88M | -344.93M | -323.7M | -304.51M | -284.05M | -266.12M | -247.47M | -231.36M |
Comprehensive Income | 16K | 35K | 50K | 107K | -47K | -10K | 103K | -121K | -180K | 339K | -26K | -453K | -745K | -1.12M | -206K | 45K | -137K | -189K |
Shareholders Equity | 164.41M | 177.37M | 189.9M | 95.51M | 109.22M | 130.84M | 147.03M | 172.8M | 199.68M | 220.47M | 245.17M | 189.31M | 202.13M | 167.84M | 186.38M | 201.87M | 217.58M | 91.64M |
Total Investments | 127.06M | 119.02M | 61.32M | 60.01M | 77.76M | 96.26M | 111.38M | 130.64M | 154.83M | 185.86M | 210.12M | 167.73M | 150.14M | 140.59M | 165.63M | 150.79M | 137.08M | 73.69M |